(Q24194970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

13 May 2020

1

Laureen M Lopez

Laureen M

Lopez

1 reference

PubMed

19 October 2023

2

David A Grimes

David A

Grimes

1 reference

PubMed

19 October 2023

3

Kenneth F Schulz

Kenneth F

Schulz

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

13 May 2020

PubMed

24788670

Cochrane Database of Systematic Reviews

19 October 2023

publication date

30 April 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

13 May 2020

volume

2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Comparison of two triphasic contraceptives with different progestogens: effects on metabolism and coagulation proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Implanon contraceptive implants: effects on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Study design for the Triphasic Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A comparative study on the effects of a contraceptive vaginal ring NuvaRing and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Lipid and biochemical changes after low-dose oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, li

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A comparative analysis of three methods of contraception: Effects on blood glucose and serum lipid profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Metabolic effects of implantable steroid contraceptives for women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Combination contraceptives: effects on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Hormonal contraceptives for contraception in overweight or obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Progestin-only contraceptives: effects on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

The insulin resistance syndrome: definition and dietary approaches to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Reflections of a whistle-blower

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Allocation concealment in randomised trials: defending against deciphering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Sample size slippages in randomised trials: exclusions and the lost and wayward

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Metabolic effects of contraceptive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Preventing chronic diseases: how many lives can we save?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Obesity and oral contraceptive pill failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

Triphasic Randomized Clinical Trial: Comparison of effects on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task f

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Metabolic effects of three new low-dose pills: a six-month experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Progestagen-only oral contraceptives: Comparison of the metabolic effects of levonorgestrel and norethisterone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Randomized prospective studies on metabolic effects of oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006133.PUB5

7 January 2021

10.1002/14651858.CD006133.PUB5

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4762468

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

release_2jcc5y7a6bf6pamqheu43qsq2i

13 May 2020

Fatcat ID

0 references

4762468

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6846331&resulttype=core&format=json

13 May 2020

24788670

1 reference

Consolidated OpenCitations Corpus – April 2017